ES2051674T3 - Derivados de benzoxazinona y benzotiazinona dotados de actividad cardiovascular. - Google Patents

Derivados de benzoxazinona y benzotiazinona dotados de actividad cardiovascular.

Info

Publication number
ES2051674T3
ES2051674T3 ES91120471T ES91120471T ES2051674T3 ES 2051674 T3 ES2051674 T3 ES 2051674T3 ES 91120471 T ES91120471 T ES 91120471T ES 91120471 T ES91120471 T ES 91120471T ES 2051674 T3 ES2051674 T3 ES 2051674T3
Authority
ES
Spain
Prior art keywords
sub
benzoxazinone
benzotiazinone
cardiovascular activity
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91120471T
Other languages
English (en)
Other versions
ES2051674T1 (es
Inventor
Alberto Sala
Francesca Benedini
Roberta Cereda
Soldato Piero Del
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Publication of ES2051674T1 publication Critical patent/ES2051674T1/es
Application granted granted Critical
Publication of ES2051674T3 publication Critical patent/ES2051674T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

DERIVADOS DE BENZOXAZINONA Y BENZOTIAZIZINONE DE FORMULA: DONDE R REPRESENTA HIDROGENO, (C SUB 2-6) ALQUILO, (C SUB 5-7) CICLOALQUILO, FENIL, FENIL SUSTITUIDO; R SUB 1 Y R SUB 2 HIDROGENO, HALOGENO, (C SUB 1-4)ALQUILO, (C SUB 1-4)ALCOXI O TRIFLUORMETIL; X ES OXIGENO O AZUFRE; Y ES (C SUB 2-6) ALQUILENO O (C SUB 5-7)CICLOALQUILENO; SALES DE ACIDO FARMACEUTICAMENTE ACEPTABLE DE LO ANTERIOR. LOS COMPUESTOS POSEEN ACTIVIDAD CARDIOVASCULAR CON ALTA ESPECIFICIDAD PARA EL DISTRITO CORONARIO.
ES91120471T 1990-12-14 1991-11-29 Derivados de benzoxazinona y benzotiazinona dotados de actividad cardiovascular. Expired - Lifetime ES2051674T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02239490A IT1244472B (it) 1990-12-14 1990-12-14 Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare

Publications (2)

Publication Number Publication Date
ES2051674T1 ES2051674T1 (es) 1994-07-01
ES2051674T3 true ES2051674T3 (es) 1995-06-16

Family

ID=11195702

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91120471T Expired - Lifetime ES2051674T3 (es) 1990-12-14 1991-11-29 Derivados de benzoxazinona y benzotiazinona dotados de actividad cardiovascular.

Country Status (22)

Country Link
US (1) US5189034A (es)
EP (1) EP0490183B1 (es)
JP (1) JP2512845B2 (es)
KR (1) KR960016124B1 (es)
AT (1) ATE121392T1 (es)
AU (1) AU644254B2 (es)
CA (1) CA2056814C (es)
DE (2) DE490183T1 (es)
DK (1) DK0490183T3 (es)
ES (1) ES2051674T3 (es)
FI (1) FI95796C (es)
GR (2) GR920300088T1 (es)
HU (1) HUT63398A (es)
IE (1) IE67625B1 (es)
IT (1) IT1244472B (es)
LV (1) LV11029B (es)
MX (1) MX9102540A (es)
NO (1) NO180585C (es)
NZ (1) NZ240978A (es)
PT (1) PT99790B (es)
TW (1) TW233296B (es)
ZA (1) ZA919496B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245351B (it) * 1991-03-19 1994-09-20 Italfarmaco Spa Isoindoli ad attivita' cardiovascolare
IT1254884B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare
IT1256023B (it) * 1992-06-10 1995-11-20 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare
CH685700A5 (fr) * 1993-03-16 1995-09-15 Cermol Sa Esters nitriques de 1,2-benzo-isothiazolyl-3(2H)one-1,1-dioxyde, procédé de préparation de ces esters et médicaments contenant ces esters.
IT1264812B1 (it) * 1993-07-28 1996-10-10 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici terapeuticamente attivi
JP4613082B2 (ja) 2005-03-14 2011-01-12 ヤンマー株式会社 作業車両のボンネット構造
US8148368B2 (en) * 2010-09-07 2012-04-03 Shaikh Riazuddin 7-nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof for treating or preventing antiviral infections
CN103687843B (zh) * 2011-10-24 2016-11-16 尼科斯科学爱尔兰公司 醌基一氧化氮供体化合物
KR102288434B1 (ko) * 2018-10-18 2021-08-12 에이치케이이노엔 주식회사 신규한 (이소프로필-트리아졸릴)피리디닐 치환된 벤조옥사지논 또는 벤조티아지논 유도체 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459748A (en) * 1967-04-28 1969-08-05 Squibb & Sons Inc Hydroxyalkylene-substituted benzoxazines and benzothiazines
US3513166A (en) * 1967-05-22 1970-05-19 Robins Co Inc A H 3-(omega-aminoalkyl)-4-substituted-1,3-benzoxazine-2-ones
GB1274553A (en) * 1969-05-06 1972-05-17 Squibb & Sons Inc Hydroxyalkylene-substituted benzoxazines and benzothiazines
JPS6137766A (ja) * 1984-07-31 1986-02-22 Sankyo Co Ltd フタルイミド誘導体およびその製造法
FR2636065B1 (fr) * 1988-09-08 1993-05-07 Fabre Sa Pierre Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique

Also Published As

Publication number Publication date
FI95796B (fi) 1995-12-15
JP2512845B2 (ja) 1996-07-03
NO180585B (no) 1997-02-03
AU8972291A (en) 1992-06-18
CA2056814C (en) 1997-01-14
PT99790A (pt) 1992-12-31
DE490183T1 (de) 1992-12-17
NO914938D0 (no) 1991-12-13
ES2051674T1 (es) 1994-07-01
NO914938L (no) 1992-06-15
FI915875A0 (fi) 1991-12-13
KR920012052A (ko) 1992-07-25
HUT63398A (en) 1993-08-30
GR920300088T1 (en) 1992-12-30
PT99790B (pt) 1999-05-31
IT9022394A0 (it) 1990-12-14
JPH0532642A (ja) 1993-02-09
NO180585C (no) 1997-05-14
EP0490183B1 (en) 1995-04-19
DK0490183T3 (da) 1995-06-26
CA2056814A1 (en) 1992-06-15
HU913950D0 (en) 1992-02-28
IE67625B1 (en) 1996-04-17
GR3015901T3 (en) 1995-07-31
US5189034A (en) 1993-02-23
IT1244472B (it) 1994-07-15
MX9102540A (es) 1992-06-01
LV11029A (lv) 1996-02-20
DE69109066T2 (de) 1995-09-21
FI915875A (fi) 1992-06-15
LV11029B (en) 1996-06-20
IT9022394A1 (it) 1992-06-14
NZ240978A (en) 1993-07-27
IE914343A1 (en) 1992-06-17
ATE121392T1 (de) 1995-05-15
AU644254B2 (en) 1993-12-02
DE69109066D1 (de) 1995-05-24
TW233296B (es) 1994-11-01
EP0490183A1 (en) 1992-06-17
FI95796C (fi) 1996-03-25
KR960016124B1 (ko) 1996-12-04
ZA919496B (en) 1992-08-26

Similar Documents

Publication Publication Date Title
AU540060B2 (en) Processes
AR241528A1 (es) Un procedimiento para la preparacion de n-(3- o 4-((alquilamino)alquil)-fenil)alcansulfonamidas y sus sales.
SE8503922L (sv) Analgetiska 1,2-bensisotiazol-3-ylpiperazin-derivat
AR240909A2 (es) Derivados de 2-(2'-alquilbenzoil) -1,3-ciclohexanodiona, composicion que los comprende y procedimiento para prepararlo"
ES2062974T3 (es) Compuestos de cefalosporina, procedimientos para su preparacion y agentes antibacterianos.
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
ATE117681T1 (de) Chinolinderivate, ihre herstellung und verwendung.
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
ES2051674T3 (es) Derivados de benzoxazinona y benzotiazinona dotados de actividad cardiovascular.
ES551274A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
ATE115136T1 (de) 4-phenylphthalazin-derivate.
ATE49211T1 (de) Dreizyklische oxindole als antientzuendungsmittel.
SE7910072L (sv) Pyrrolo- eller pyrido(2,1-c)(1,4)tiaziner eller -tiazepiner
ES547129A0 (es) Un procedimiento para la produccion de derivados de benzoilurea.
ES2073460T3 (es) Fenilalquilaminas y los fungicidas que las contienen.
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
ZA846825B (en) 3-phenyl-4-methoxycarbonylpyrazoles and their use for controling undesirable plant growth
FR2443460A1 (fr) Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs
FI883507A (fi) Naftotiazepinderivat och deras framstaellning.
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
EA199700299A1 (ru) Азольные соединения с противогрибковой (антимикозной) активностью, применяемые для лечения людей и в ветеринарии
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
SU803375A1 (ru) Производные 5-м-нитробензилиденселеназолидиндиона-2,4, обладающие психотропной активностью
TH3947EX (th) เบนซามีดชนิดใหม่

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 490183

Country of ref document: ES